Bromodomain-Containing Protein 4: A Dynamic Regulator of Breast Cancer Metastasis through Modulation of the Extracellular Matrix
Related Experiment Video
Updated: May 25, 2026
Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
Published on: May 19, 2016
1Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Metastasis is an extremely complex process that accounts for most cancer-related deaths. Malignant primary tumors can be removed surgically, but the cells that migrate, invade, and proliferate at distant organs are often the cells that prove most difficult to target therapeutically. There is growing evidence that host factors outside of the primary tumors are of major importance in the development of metastasis. Recently, we have shown that the bromodomain-containing protein 4 or bromodomain 4 (Brd4) functions as an inherited susceptibility gene for breast cancer progression and metastasis. In this paper, we will discuss that host genetic background on which a tumor arises can significantly alter the biology of the subsequent metastatic disease, and we will focus on the role of Brd4 in regulating metastasis susceptibility.
Insights
Bromodomain 4 (Brd4) acts as a susceptibility gene influencing breast cancer metastasis. Host genetic factors significantly impact metastatic disease progression and therapeutic targeting challenges.
Area of Science:
- Oncology
- Cancer Biology
- Genetics
Background:
- Metastasis is a complex process responsible for most cancer deaths.
- Therapeutic targeting of metastatic cells remains a significant challenge.
- Host factors, beyond the primary tumor, play a crucial role in metastasis development.
Purpose of the Study:
- To investigate the role of bromodomain 4 (Brd4) in breast cancer metastasis.
- To explore how host genetic background influences metastatic disease.
- To understand Brd4's function in regulating metastasis susceptibility.
Main Methods:
- Analysis of Brd4's function in breast cancer progression.
- Investigating the impact of host genetic factors on metastasis.
- Focusing on Brd4's regulatory role in metastasis susceptibility.
Main Results:
- Bromodomain 4 (Brd4) identified as a key factor in inherited susceptibility to breast cancer progression and metastasis.
- Demonstrated that host genetic background significantly alters metastatic disease biology.
- Highlighted Brd4's critical role in modulating metastasis susceptibility.
Conclusions:
- Brd4 is a critical host factor influencing breast cancer metastasis.
- Understanding host genetics, particularly Brd4, is vital for developing effective anti-metastasis therapies.
- Host genetic background significantly impacts cancer progression and therapeutic outcomes.
Related Concept Videos
01:29The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
01:42The Extracellular Matrix
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:17The Tumor Microenvironment
01:23Role of Matrix Metalloproteases in Degradation of ECM
A...
02:23Abnormal Proliferation